HLA-G and neoplasm: In cancer, abnormal expression of HLA-G is considered a key strategy of tumor cells to evade immune surveillance, which is strongly supported by the high incidence of tumors in patients treated with immunosuppressive agents after organ and stem cell transplantation (78).